Coronary/Structural Heart

Acasti Pharma Awarded Composition-of-Matter Patent by the U.S. Patent and Trademark Office

LAVAL, Québec, July 24, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ:ACST) (TSX-V:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced it has received a Notice of Allowance […]

HeartStitch® Presents Initial Clinical Results Of New Tricuspid Valve Repair At CSI Frankfurt Clinical Congresses

FRANKFURT, Germany, July 24, 2018 /PRNewswire/ — HeartStitch® has presented initial clinical data of its revolutionary tricuspid valve repair technique using only surgical sutures and pledgets to repair and promote remodeling of the tricuspid valve in 30 patients suffering from tricuspid regurgitation (TR). Prof. Anthony Nobles, Chairman, CEO and Chief Clinical Officer of HeartStitch®, Inc. […]

Nation’s Top Heart Disease Patient Advocates Create Task Force Aimed at Improving Access, Research, and Awareness on Heart Valve Disease Detection and Treatment

WASHINGTON, July 24, 2018 /PRNewswire/ — The nation’s leading heart disease patient advocates announced today the launch of the Heart Valve Disease Policy Task Force, a coalition of non-profit organizations uniting for a common voice in support of improved access, research, and awareness on heart valve disease detection and treatment. The Heart Valve Disease […]

Intra-Cellular Therapies Announces Publication Highlighting ITI-214 Mechanism of Action and Describing Positive Results in Preclinical Models of Heart Failure

NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) today announced the online publication of a report in the journal Circulation describing the mechanism of action of its phosphodiesterase (PDE) Type 1 inhibitor, ITI-214, and its potential use for the treatment of heart failure.  In these preclinical studies, Johns […]

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

MARLBOROUGH, Mass., July 20, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel® Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter […]

Corindus Announces Significant Progress in the Development of Remote Vascular Robotic Technology with the CorPath GRX® System

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that Ryan Madder, M.D., an interventional cardiologist at Spectrum Health, has successfully completed a remote percutaneous coronary intervention (PCI) in a porcine model using the CorPath GRX System from a location greater than […]

Boehringer Ingelheim and Lilly announce Tradjenta’s CARMELINA® cardiovascular outcome trial meets primary endpoint

RIDGEFIELD, Conn. and INDIANAPOLIS, July 19, 2018 /PRNewswire/ — CARMELINA® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke (3-point MACE), with Tradjenta® demonstrating similar cardiovascular safety compared with […]

Fujifilm Presents Cardiovascular Imaging Solutions at the World Society for Pediatric and Congenital Heart Surgery’s 6th Scientific Meeting

STAMFORD, Conn., July 19, 2018 /PRNewswire/ — (Booth 106) — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Informatics solutions, will demonstrate Synapse® Cardiovascular, its comprehensive enterprise solution for cardiology, at the World Society for Pediatric and Congenital Heart Surgery’s (WSPCHS) 6thscientific meeting. This meeting is the premier gathering of the largest professional […]

Cook® Regentec Announces First U.S. Clinical Use of Advance® CS Coronary Sinus Infusion Catheter to Deliver a Therapeutic in Heart Failure Patients

INDIANAPOLIS, July 18, 2018 /PRNewswire/ — Cook Regentec announced today the first clinical use in the United Statesof the Advance CS Coronary Sinus Infusion Catheter and Compass® CT Disposable Pressure Transducer to deliver a therapeutic in heart failure patients. The Advance CS Coronary Sinus Infusion Catheter is a percutaneous balloon infusion catheter designed […]

OMEICOS Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation

BERLIN–(BUSINESS WIRE)–OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced results from its first-in-human clinical study for OMT-28. The study met its primary goal with OMT-28 exhibiting an excellent tolerability profile and showing no safety signals […]